Bayshore HealthCare

bayshore.ca

Bayshore HealthCare has been dedicated to enhancing the quality of life, dignity and independence of Canadians in their homes since 1966. Canadian owned and operated, we are the country's largest provider of home and community health care services, with more than 50 home care offices, 20 community care clinics and 8,000 employees. Offering a wide range of home and community health services, we strive to make a difference in our clients' lives – every visit, every time. Our nursing, personal care, home support and companionship services are available privately as well as through government care programs, personal and group insurance plans and workplace safety insurance. We deliver care to more than 70,000 clients annually.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

CNS PHARMACEUTICALS ANNOUNCES US DRUG MANUFACTURING MILESTONES

CNS Pharmaceuticals | September 03, 2020

news image

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, today provides an update on progress for the U.S. manufacturing of Berubicin, the Company's lead drug candidate, in preparation for upcoming clinical trials. As previously announced, the Company implemented a dual-track drug product manufacturing strategy and eng...

Read More

PHARMA TECH, PRACTICE MANAGEMENT

LILLY LAUNCHES END-TO-END DIGITAL HEALTHCARE EXPERIENCE THROUGH LILLYDIRECT

PR Newswire | January 05, 2024

news image

Eli Lilly and Company today announced LillyDirect, a new digital healthcare experience for patients in the U.S. living with obesity, migraine and diabetes. LillyDirect offers disease management resources, including access to independent healthcare providers*, tailored support, and direct home delivery of select Lilly medicines through third-party pharmacy dispensing services. "A complex U.S. healthcare system adds to the burdens patients face when managing a chronic disease...

Read More

Pharma Tech

BEIGENE-NOVARTIS PD-1 DEAL; SINOVAC VACCINE; CELLTRION ANTIBODY COVID-19 DATA

Novartis | January 19, 2021

news image

Novartis plunked down up to $2.2 billion for BeiGene's China-approved PD-1 drug tislelizumab to complement its own checkpoint inhibitor. Hear what BeiGene CEO John Oyler has to say about tislelizumab's position in and outside China. Sinovac's COVID-19 vaccine reported confusing data from Brazil, raising doubt about its true efficacy. Celltron's anti-SARS-CoV-2 antibody improved patients' outcomes in a phase 2/3 trial. And more. Novartis paid $650 million upfron...

Read More

Pharmacy Market

NANOTEMPER TECHNOLOGIES UNVEILS BIOTINYLATED TARGET LABELING KIT, EMPOWERING SCIENTISTS IN PHARMA INDUSTRY TO TACKLE CHALLENGING DRUG TARGETS

Businesswire | June 30, 2023

news image

NanoTemper Technologies, creator of biophysical tools for drug discovery, today, proudly announced the launch of their highly anticipated Biotinylated Target Labeling Kit, expanding the molecular interaction analysis toolkit for scientists working with complex or undruggable targets, filling a vital gap in screening and hit validation workflows in the pharma industry. This new kit combined with NanoTemper’s exclusive Spectral Shift technology is the preferred orthogonal me...

Read More
news image

CNS PHARMACEUTICALS ANNOUNCES US DRUG MANUFACTURING MILESTONES

CNS Pharmaceuticals | September 03, 2020

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, today provides an update on progress for the U.S. manufacturing of Berubicin, the Company's lead drug candidate, in preparation for upcoming clinical trials. As previously announced, the Company implemented a dual-track drug product manufacturing strategy and eng...

Read More
news image

PHARMA TECH, PRACTICE MANAGEMENT

LILLY LAUNCHES END-TO-END DIGITAL HEALTHCARE EXPERIENCE THROUGH LILLYDIRECT

PR Newswire | January 05, 2024

Eli Lilly and Company today announced LillyDirect, a new digital healthcare experience for patients in the U.S. living with obesity, migraine and diabetes. LillyDirect offers disease management resources, including access to independent healthcare providers*, tailored support, and direct home delivery of select Lilly medicines through third-party pharmacy dispensing services. "A complex U.S. healthcare system adds to the burdens patients face when managing a chronic disease...

Read More
news image

Pharma Tech

BEIGENE-NOVARTIS PD-1 DEAL; SINOVAC VACCINE; CELLTRION ANTIBODY COVID-19 DATA

Novartis | January 19, 2021

Novartis plunked down up to $2.2 billion for BeiGene's China-approved PD-1 drug tislelizumab to complement its own checkpoint inhibitor. Hear what BeiGene CEO John Oyler has to say about tislelizumab's position in and outside China. Sinovac's COVID-19 vaccine reported confusing data from Brazil, raising doubt about its true efficacy. Celltron's anti-SARS-CoV-2 antibody improved patients' outcomes in a phase 2/3 trial. And more. Novartis paid $650 million upfron...

Read More
news image

Pharmacy Market

NANOTEMPER TECHNOLOGIES UNVEILS BIOTINYLATED TARGET LABELING KIT, EMPOWERING SCIENTISTS IN PHARMA INDUSTRY TO TACKLE CHALLENGING DRUG TARGETS

Businesswire | June 30, 2023

NanoTemper Technologies, creator of biophysical tools for drug discovery, today, proudly announced the launch of their highly anticipated Biotinylated Target Labeling Kit, expanding the molecular interaction analysis toolkit for scientists working with complex or undruggable targets, filling a vital gap in screening and hit validation workflows in the pharma industry. This new kit combined with NanoTemper’s exclusive Spectral Shift technology is the preferred orthogonal me...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us